StockData
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd (RADX) income statement

RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.63−0.04 (-6.33%)

Close on Nov 20, 2026Market cap $7.45MP/E –Yield –

See a number that looks wrong?